Nanocarrier-Based Management of Venous and Arterial Thrombosis

• Published in: Crystals (Basel) Vol. 12; no. 4; p. 450
• Main Authors: Haba, Mihai Ștefan Cristian, Șerban, Dragomir N., Șerban, Ionela Lăcrămioara, Tudorancea, Ivona Maria, Haba, Raluca Maria, Mărănducă, Minela Aida, Tănase, Daniela Maria, Iliescu, Radu, Tudorancea, Ionuț
• Format: Journal Article
• Language: English
• Published: Basel MDPI AG 01.04.2022
• Subjects: Anticoagulants; arterial thrombosis; Biomarkers; Blood clots; Chronic illnesses; Heart attacks; Heart failure; Hemorrhage; Injury prevention; Ligands; Magnetic properties; Magnetic resonance imaging; Medical diagnosis; Molecular structure; Mortality; nanocarriers; Nanoparticles; Nanotechnology; Pathophysiology; Peptides; Polyethylene glycol; Pulmonary arteries; Pulmonary embolisms; Thromboembolism; Thrombosis; Tomography; Trauma; Veins & arteries; venous thrombosis; United States > US
• ISSN: 2073-4352; 2073-4352
• DOI: 10.3390/cryst12040450

Cardiovascular diseases represent the leading cause of mortality worldwide, with recent epidemiological studies revealing an increasing trend of prevalence and incidence globally. Among cardiovascular disorders, both arterial and venous thrombosis and particularly their acute life-threating complications such as ischemic stroke, acute myocardial infarction, deep venous thrombosis and pulmonary embolism are responsible for more than 25% of all deaths worldwide. The modern approach following progresses in anticoagulant, thrombolytic and antiaggregant therapies has significantly improved the prognoses of these conditions in the last past decades. However, several challenges still remain such as achieving the optimal drug concentration at the injured site, reducing the shortcomings of drug resistance and the incidence of life-threatening hemorrhages. Nanomedicine is a well-known field of medicine in which atomic and molecular structures ranging between 0.1–100 nm are used in various domains due to their specific mechanical, electrical, thermal and magnetic properties. Recent experimental and clinical evidence have shown that nanotechnology could be a safe, effective and an appealing approach for various non-cardiovascular and cardiovascular diseases such as thromboembolic conditions. In this review, we have described the most promising nanotechnology-based approaches not only for the diagnosis, but also for the treatment of vascular thrombotic diseases.